Market Overview

UPDATE: Goldman Sachs Upgrades Vitamin Shoppe to Buy on Valuation, Secular Growth Outlook

Related VSI
Vitamin Shoppe Downgraded At JPMorgan As Industry Loses Muscle
Barclays Shrugs At Food & Staples Sector, Interest Piqued By Just 3 Names
Vitamin Shoppe: Close To 6 Year Lows With Potential Upside (Seeking Alpha)

Goldman Sachs upgraded Vitamin Shoppe (NYSE: VSI) from Neutral to Buy and raised the price target to $65.00.

Goldman Sachs noted, "Like many growth names in our coverage, VSI has experienced multiple compression of late. We still like the supplement sector's secular growth. Moreover, we like VSI's incremental pursuit of own-brand product and international expansion, which we think brings it marginally closer to GNC's more lucrative operating model. VSI now trades near longrun relative P/E troughs, presenting us with an opportunity to buy into growth at a relative discount."

Vitamin Shoppe closed at $50.62 on Monday.

Latest Ratings for VSI

Oct 2016JP MorganDowngradesOverweightNeutral
Sep 2016BarclaysInitiates Coverage onEqual-Weight
Apr 2016WedbushInitiates Coverage onOutperform

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Analyst Ratings


Related Articles (VSI)

View Comments and Join the Discussion!